Skip to main content
. 2023 Oct 18;14:1285296. doi: 10.3389/fimmu.2023.1285296

Figure 1.

Figure 1

Clinical, pathological, and genetical characteristics of the patient before treatment. (A) Representative magnetic resonance imaging of the lesions before treatment. (B) Representative pathological images of the biopsy tumor tissue before treatment. (C) Abundance of gene mutation of the biopsy tumor tissue before treatment. (D) Tumor mutation burden distribution in liver cancer patients sequenced in Geneplus. (E) Coverage comparison of HLA-A supertype, HLA-B supertype, and HLA-C supertype.